A new class of antiviral directed at HBV capsid proteinNair, Smita⋅VanNieuwenhze, Michael S and Zlotnick, AdamNational Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID) (ID: 1R43AI181057-01), $306,500USD, 2024-01-01 -- 2024-12-31